we pave the way for biotechs

News

Eckert & Ziegler will be admitted to the MSCI Germany Small Cap Index

2019-05-14 / Berlin-based Eckert & Ziegler Strahlen- und Medizintechnik AG (ISIN DE0005659700), a specialist in isotope-related applications in medicine, science and industry will be admitted to the MSCI Germany Small Cap Index as of 28 May 2019. This decision was announced by MSCI Inc., a leading provider of research-based indexes, after its semi-annual index review for the MSCI equity indexes. In addition to the high transparency requirements of the Prime Standard, the Eckert & Ziegler shares thereby also fulfill the relevant index criteria such as market capitalization, momentum and yield.

“The strong increase in the value of the share over the past few quarters has confirmed our strategy to focus Eckert & Ziegler more on innovative pharmaceuticals for cancer treatment”, explained Dr. Andreas Eckert, CEO of Eckert & Ziegler AG. „We are delighted by the admission to the MSCI Germany Small Cap Index which will further raise the interest in our share and extend our presence in the capital markets.”

The MSCI Germany Small Cap Index currently is composed by 113 companies of the German equity market.


About Eckert & Ziegler.
Eckert & Ziegler Strahlen- und Medizintechnik AG (ISIN DE0005659700), with around 800 employees, is one of the world's largest providers of isotope-related components for radiation therapy and nuclear medicine

Back to the list

MDC
FMP
Charite
Campus Berlin-Buch
Berlin Buch